Drugs / homatropine
homatropine
also known as
Dl-homatropine hydrobromide · HOMATROPINE HYDROBROMIDE · Homatropini hydrobromidum · NSC-757047
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01408069 | — | — | EMS | Withdrawn | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01168375 Comparator | — | corneal disorder | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02344732 Background | Oct 2013 → Oct 2014 | corneal disorder | Universiti Sains Malaysia | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | homatropine | “1 to 2 tablets ergotamine 1mg + caffeine 100mg + acetylsalicylic 350 mg + homatropine 1,2 mg” NCT01408069 ↗ |
| Known as | Dl-homatropine hydrobromide | ChEMBL registry synonym — accepted as the source's own label CHEMBL1618018 ↗ |
| Known as | HOMATROPINE HYDROBROMIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1618018 ↗ |
| Known as | Homatropini hydrobromidum | ChEMBL registry synonym — accepted as the source's own label CHEMBL1618018 ↗ |
| Known as | NSC-757047 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1618018 ↗ |
| Modality | Small molecule | — CHEMBL1618018 ↗ |
| Route | Other | “cycloplegic (homatropine) eye drop every 8 hours” NCT01168375 ↗ |